SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-02-002292
Filing Date
2002-11-21
Accepted
2002-11-21 16:03:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A-DISCOVERY LABORATORIES-ORBIMED INC sch13ga-discovery_112002.txt SC 13G/A 10148
3 EXH. 1.1 TO SCH. 13G/A FOR DISCOVERY LAB ex1-1tosch13ga_112002.txt EX-1.1 2253
4 EXH. 2.1 TO SCH. 13G/A FOR DISCOVERY LAB ex2-1tosch13ga_112002.txt EX-2.1 817
  Complete submission text file 0000947871-02-002292.txt   15666
Mailing Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901
Business Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901 2152404699
DISCOVERY LABORATORIES INC /DE/ (Subject) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48466 | Film No.: 02836200
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 41 MADISON AVENUE 40TH FLOOR NEW YORK NY 10010 2126850800
ORBIMED ADVISERS INC /CT (Filed by) CIK: 0001033248 (see all company filings)